Literature DB >> 3290017

Prospective analysis of islet cell antibodies in children with type 1 (insulin-dependent) diabetes.

H Kolb1, K Dannehl, D Grüneklee, J Zielasek, J Bertrams, A Hübinger, F A Gries.   

Abstract

The prevalence of islet cell antibodies in children with Type 1 (insulin-dependent) diabetes was determined in a cohort of 678 children. The natural course of islet cell antibodies was followed in 375 children at 1 year, 252 and 135 children after 2 and 3 years respectively. Islet cell antibodies were determined by indirect immunofluorescence on cryostat sections of human pancreas. At diagnosis of diabetes 85% of the children had detectable islet cell antibodies (mean titre 10.4). After 3 years 62% of the children were still islet cell antibody positive (mean titre 2.9) indicating a greater persistence of islet cell antibodies than described in earlier studies. In this large cohort a significant correlation between islet cell antibody prevalence or persistence and sex, age or HLA-DR type was not observed except for a faster loss of islet cell antibodies in very young boys and in patients lacking HLA-DR types 3 and 4. Complement fixing islet cell antibodies correlated with high titre islet cell antibodies. Greater persistence of islet cell antibodies was seen for cases with high antibody titre and in children with diagnosis of diabetes during the first half of the year.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290017     DOI: 10.1007/bf00290583

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Incidence and significance of islet-cell autoantibodies in different types of diabetes mellitus.

Authors:  G F Del Prete; C Betterle; D Padovan; G Erle; A Toffolo; G Bersahi
Journal:  Diabetes       Date:  1977-10       Impact factor: 9.461

2.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.

Authors:  G F Bottazzo; A Florin-Christensen; D Doniach
Journal:  Lancet       Date:  1974-11-30       Impact factor: 79.321

3.  Islet-cell antibodies are seldom transient.

Authors:  W Riley; N Maclaren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  Islet cell autoantibodies: which method?

Authors: 
Journal:  Lancet       Date:  1983-02-26       Impact factor: 79.321

5.  Islet cell antibodies and histocompatibility antigens (HLA) in insulin-dependent diabetics and their first-degree relatives.

Authors:  J Barbosa; B Chavers; T Dunsworth; A Michael
Journal:  Diabetes       Date:  1982-07       Impact factor: 9.461

6.  Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes, coexistent autoimmune disease, and HLA type.

Authors:  W J Irvine; C J McCallum; R S Gray; C J Campbell; L J Duncan; J W Farquhar; H Vaughan; P J Morris
Journal:  Diabetes       Date:  1977-02       Impact factor: 9.461

7.  Humoral immunity in type 1 diabetes mellitus: a prospective study.

Authors:  D Q Borsey; U Di Mario; W J Irvine; R S Gray; K Guy; J Weston; J Peutherer; L J Duncan
Journal:  J Clin Lab Immunol       Date:  1983-05

8.  Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes.

Authors:  K M Spencer; A Tarn; B M Dean; J Lister; G F Bottazzo
Journal:  Lancet       Date:  1984-04-07       Impact factor: 79.321

9.  Clinical time-course and characteristics of islet cell cytoplasmatic antibodies in childhood diabetes.

Authors:  G J Bruining; J Molenaar; C W Tuk; J Lindeman; H A Bruining; B Marner
Journal:  Diabetologia       Date:  1984-01       Impact factor: 10.122

10.  Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.

Authors:  B Marner; T Agner; C Binder; A Lernmark; J Nerup; T Mandrup-Poulsen; S Walldorff
Journal:  Diabetologia       Date:  1985-12       Impact factor: 10.122

View more
  10 in total

1.  HLA antigens in Spanish type 1 diabetic population. Correlations with clinical, biological and autoimmune markers.

Authors:  A Goday; E Motaña; G Ercilla; J Fernandez; R Gomis; E Vilardell
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

2.  Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass.

Authors:  E F Lampeter; M Tubes; C Klemens; U Brocker; J Friemann; V Kolb-Bachofen; F A Gries; H Kolb
Journal:  Diabetologia       Date:  1995-12       Impact factor: 10.122

3.  Glutamic acid decarboxylase antibodies, autonomic nerve antibodies and autonomic neuropathy in diabetic patients.

Authors:  G Sundkvist; L A Velloso; O Kämpe; S L Rabinowe; S A Ivarsson; B Lilja; F A Karlsson
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

4.  Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.

Authors:  M Landin-Olsson; K O Nilsson; A Lernmark; G Sundkvist
Journal:  Diabetologia       Date:  1990-09       Impact factor: 10.122

5.  Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children.

Authors:  M Landin-Olsson; A Karlsson; G Dahlquist; L Blom; A Lernmark; G Sundkvist
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

6.  Autoantibodies to the islet antigen ICA69 occur in IDDM and in rheumatoid arthritis.

Authors:  S Martin; J Kardorf; B Schulte; E F Lampeter; F A Gries; I Melchers; R Wagner; J Bertrams; B O Roep; A Pfützner
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies.

Authors:  K Böhmer; H Keilacker; B Kuglin; A Hübinger; J Bertrams; F A Gries; H Kolb
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

8.  Inflammatory islet damage in patients bearing HLA-DR 3 and/or DR 4 haplotypes does not lead to islet autoimmunity.

Authors:  E F Lampeter; I Seifert; D Lohmann; J W Heise; J Bertrams; M R Christie; V Kolb-Bachofen; H Kolb
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

9.  Indications for a more aggressive disease process in newly diagnosed insulin-dependent diabetic children in northern than in southern Europe.

Authors:  U Samuelsson; J Ludvigsson; G F Bottazzo; M Shattock; S Adolfsson; D Becker; E Cacciari; F Chiarelli; G Chiumello; I Deschamps
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

10.  Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study.

Authors:  C F Verge; N J Howard; M J Rowley; I R Mackay; P Z Zimmet; M Egan; H Hulinska; I Hulinsky; R A Silvestrini; S Kamath
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.